{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:23:41Z","timestamp":1759710221304,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.mehy.2019.109437","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T01:54:43Z","timestamp":1571363683000},"page":"109437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Increased cancer risk in polycystic ovary syndrome: An (un)sympathetic connection?"],"prefix":"10.1016","volume":"134","author":[{"given":"Boris","family":"Mravec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Tibensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.109437_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.mehy.2019.109437_b0010","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.mehy.2019.109437_b0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mehy.2019.109437_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2014.11.012","article-title":"Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study","volume":"136","author":"Gottschau","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.mehy.2019.109437_b0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamaoncol.2018.5188","article-title":"Association between polycystic ovary syndrome and cancer risk","volume":"5","author":"Yin","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.mehy.2019.109437_b0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ygyno.2013.06.032","article-title":"Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?","volume":"131","author":"Shafiee","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.mehy.2019.109437_b0035","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1152\/ajpendo.00725.2007","article-title":"Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?","volume":"294","author":"Sverrisdottir","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mehy.2019.109437_b0040","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cen.12803","article-title":"Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance","volume":"83","author":"Lambert","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mehy.2019.109437_b0045","first-page":"7","article-title":"Correlation between physiologic and osteopathic measures of sympathetic activity in women with polycystic ovary syndrome","volume":"119","author":"Davis","year":"2019","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.mehy.2019.109437_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2007.08.037","article-title":"Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome","volume":"130","author":"Tekin","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mehy.2019.109437_b0055","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1210\/jc.2019-00065","article-title":"Regional cerebral activation accompanies sympathoexcitation in women with polycystic ovary syndrome","volume":"104","author":"Lansdown","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2019.109437_b0060","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1210\/endo.133.6.8243293","article-title":"Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation","volume":"133","author":"Barria","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2019.109437_b0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/endo.141.3.7395","article-title":"An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat","volume":"141","author":"Lara","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2019.109437_b0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.12003","article-title":"The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?","volume":"77","author":"Lansdown","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mehy.2019.109437_b0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1385\/ENDO:28:3:319","article-title":"Role of stress and sympathetic innervation in the development of polycystic ovary syndrome","volume":"28","author":"Greiner","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.mehy.2019.109437_b0080","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/2151509a0","article-title":"Transformation of the histochemical profile of skeletal muscle by \u201cforeign\u201d innervation","volume":"215","author":"Karpati","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2019.109437_b0085","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/mus.21106","article-title":"Nerve-dependent changes in skeletal muscle myosin heavy chain after experimental denervation and cross-reinnervation and in a demyelinating mouse model of Charcot-Marie-Tooth disease type 1A","volume":"38","author":"Maggs","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mehy.2019.109437_b0090","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/eurheartj\/ehi492","article-title":"Increased gene expression of collagen Types I and III is inhibited by beta-receptor blockade in patients with dilated cardiomyopathy","volume":"26","author":"Shigeyama","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2019.109437_b0095","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2019.109437_b0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.psyneuen.2007.02.013","article-title":"Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones","volume":"32","author":"Flint","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.mehy.2019.109437_b0105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jid.2014.373","article-title":"Inhibition of human melanoma growth by a non-cardioselective beta-blocker","volume":"135","author":"Wrobel","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2019.109437_b0110","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ncomms2413","article-title":"Src activation by beta-adrenoreceptors is a key switch for tumour metastasis","volume":"4","author":"Armaiz-Pena","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.mehy.2019.109437_b0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10549-010-0822-2","article-title":"The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells","volume":"125","author":"Shi","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.mehy.2019.109437_b0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2016.08.016","article-title":"Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells","volume":"59","author":"Huan","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2019.109437_b0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000054276","article-title":"Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors","volume":"8","author":"Ben-Eliyahu","year":"2000","journal-title":"NeuroImmunoModulation"},{"key":"10.1016\/j.mehy.2019.109437_b0130","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/carcin\/10.9.1753","article-title":"Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line","volume":"10","author":"Schuller","year":"1989","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mehy.2019.109437_b0135","first-page":"889","article-title":"Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via beta-adrenergic receptor-dependent activation of P38\/MAPK pathway","volume":"59","author":"Huang","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.mehy.2019.109437_b0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4149\/neo_2011_05_424","article-title":"Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats","volume":"58","author":"Lackovicova","year":"2011","journal-title":"Neoplasma"},{"key":"10.1016\/j.mehy.2019.109437_b0145","first-page":"1","article-title":"Sympathectomy reduces tumor weight and affects expression of tumor-related genes in melanoma tissue in the mouse","author":"Horvathova","year":"2016","journal-title":"Stress"},{"key":"10.1016\/j.mehy.2019.109437_b0150","first-page":"1625","article-title":"Adrenergic modulation of AMPKdependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer","volume":"54","author":"Zhi","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.mehy.2019.109437_b0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2008.10.005","article-title":"Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression","volume":"23","author":"Yang","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2019.109437_b0160","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/ijc.25589","article-title":"Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism","volume":"128","author":"Park","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2019.109437_b0165","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/ncomms10634","article-title":"Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination","volume":"7","author":"Le","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.mehy.2019.109437_b0170","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","article-title":"Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2019.109437_b0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","article-title":"Stress hormone-mediated invasion of ovarian cancer cells","volume":"12","author":"Sood","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2019.109437_b0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.mehy.2019.109437_b0185","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","article-title":"The sympathetic nervous system induces a metastatic switch in primary breast cancer","volume":"70","author":"Sloan","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2019.109437_b0190","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.21723","article-title":"The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB\/c nude mice is inhibited by beta-blockers","volume":"118","author":"Palm","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2019.109437_b0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature10368","article-title":"A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1","volume":"477","author":"Hara","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2019.109437_b0200","doi-asserted-by":"crossref","first-page":"1236361","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mehy.2019.109437_b0205","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.semcancer.2013.08.009","article-title":"beta-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy","volume":"23","author":"Tang","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.mehy.2019.109437_b0210","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: beta-adrenergic signaling in cancer","volume":"18","author":"Cole","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2019.109437_b0215","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e82","article-title":"Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study","volume":"29","author":"Baek","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.mehy.2019.109437_b0220","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1158\/0008-5472.CAN-17-0108","article-title":"Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma","volume":"77","author":"Udumyan","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2019.109437_b0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2908","article-title":"Propranolol for off-label treatment of patients with melanoma: results from a cohort study","volume":"4","author":"De Giorgi","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.mehy.2019.109437_b0230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.semcancer.2007.12.002","article-title":"Neurobiology of cancer: Interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain","volume":"18","author":"Mravec","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.mehy.2019.109437_b0235","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1470-2045(09)70337-7","article-title":"Role of nervous system in cancer aetiopathogenesis","volume":"11","author":"Ondicova","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.mehy.2019.109437_b0240","first-page":"119","article-title":"Effect of the nervous system on cancer: analysis of clinical studies","volume":"120","author":"Mravec","year":"2019","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.mehy.2019.109437_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/789174","article-title":"Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms","volume":"2012","author":"Arcidiacono","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.mehy.2019.109437_b0250","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2019.109437_b0255","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.mehy.2019.109437_b0260","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3389\/fphys.2018.01486","article-title":"Effect of central sympathoinhibition with moxonidine on sympathetic nervous activity in polycystic ovary syndrome-a randomized controlled trial","author":"Shorakae","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.mehy.2019.109437_b0265","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1185\/03007990903533681","article-title":"Effects of beta-blockers on glucose and lipid metabolism","volume":"26","author":"Fonseca","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.mehy.2019.109437_b0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1515\/jbcpp-2018-0081","article-title":"Sympathovagal imbalance and neurophysiologic cognitive assessment using evoked potentials in polycystic ovary syndrome in young adolescents \u2013 a cross-sectional study","volume":"30","author":"Velusami","year":"2018","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.mehy.2019.109437_b0275","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1542-474X.2006.00122.x","article-title":"Heart rate variability in young women with polycystic ovary syndrome","volume":"11","author":"Yildirir","year":"2006","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.mehy.2019.109437_b0280","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijcard.2015.09.031","article-title":"Aerobic exercise improves cardiac autonomic modulation in women with polycystic ovary syndrome","volume":"202","author":"Sa","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mehy.2019.109437_b0285","article-title":"Acupuncture effect and central autonomic regulation","volume":"2013","author":"Li","year":"2013","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771930965X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771930965X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:19:23Z","timestamp":1759691963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771930965X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":57,"alternative-id":["S030698771930965X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109437","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased cancer risk in polycystic ovary syndrome: An (un)sympathetic connection?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109437"}}